The 32nd Meeting of Japanese Society of Hepato-Biliary-Pancreatic Surgery

Program

Special SessionSymposiumVideo symposium
Panel discussionWorkshopVideo session
Requested SessionFree Paper (Oral/Poster)

Special Session

[ SS-1 ]Advanced HBP surgery -AI, Imaging technology-
Lectures on advanced imaging technology in the field of hepato-biliary-pancreatic surgery
[ SS-2 ]Advanced HBP surgery -New surgical device, Robotic surgery-
Lectures on advanced surgical technology in the field of hepato-biliary-pancreatic surgery
[ SS-3 ]Expert Consensus Meeting -Precision anatomy for minimally invasive HBP surgery-
Expert discussion on anatomical structures for safe minimally invasive HBP surgery
[ SS-4 ]Open discussion with Asian U-40 surgeons -Prevention of pancreatic fistula development-
(Open call for abstract)
We would like to discuss the various strategies to reduce the incidence of pancreatic fistula among young surgeons in Asian countries.

Symposium (Open call for abstracts)

[ SY-1 ]Liver transplantation for HCC: New expanded indications
The Milan criteria are a generally accepted set of criteria used to assess the suitability of patients with hepatocellular carcinoma (HCC) to undergo liver transplantation. Many different expanded criteria have been proposed but not yet established. In this session, we would like to discuss the expanded indication criteria for patients with HCC beyond the Milan criteria.
[ SY-2 ]Best strategy to treat multiple colorectal liver metastases using multimodal therapy and surgery
It has become challenging to determine the most appropriate time and method of intervention for multiple liver metastases secondary to colorectal cancer as there are several diagnostic and treatment modalities today owing to technological advancements in the medical field. In this session, we would like you to present your radical treatment strategy for multiple liver metastases due to colorectal cancer.
[ SY-3 ]New criteria of resectability for pancreatic cancer
The NCCN Guidelines for pancreatic adenocarcinoma (PDAC) define the resectability status of pancreatic cancer based on MDCT images. However, early recurrence has been reported in cases diagnosed as Resectable PDAC using MDCT images. In this session, we would like to you to present your strategy of diagnosis and treatment for PDAC and discuss new evaluation methods of resectability status (including tumor markers and bio markers.)
[ SY-4 ]Assessing difficulty of HBP surgery
HBP surgery is generally considered technically difficult; however, the level of difficulty varies among cases depending on various case-specific factors, such as the presence of inflammation. Therefore, performing preoperative objective evaluation of the surgical difficulty level for each case might help improve surgical outcomes. In this session, we would like you to suggest methods to preoperatively assess the difficulty level of HBP surgery.
[ SY-5 ]Optimal preoperative biliary drainage for malignant biliary obstruction in HBP surgery
The methods of and need for preoperative biliary drainage before HBP surgery have been recently discussed. It has been reported that combined cholangitis increases the incidence of postoperative complications after HBP surgery. In this session, we would like you to present how preoperative biliary drainage is performed at each facility for malignant biliary obstruction, and discuss the optimal drainage method.

Video symposium (Open call for abstracts)

[ VSY-1 ]Navigation and image-guided liver surgery
To ensure safety and curability in liver resection, it is essential to understand the precise anatomy of the liver. In this session, we would like you to demonstrate hepatic resection using the latest navigation system such as 3DCT images and real-time navigation system used at each facility.
[ VSY-2 ]Extended liver resection for hilar cholangiocarcinoma with vascular involvement
Surgical resection is the only radical treatment option for patients with hilar cholangiocarcinoma. However, surgical resection for hilar cholangiocarcinoma becomes much more difficult and invasive in cases with hepatic artery invasion. In this session, you are invited to present your video of the surgery with concomitant resection of hepatic artery for hilar cholangiocarcinoma.
[ VSY-3 ]Laparoscopic cholecystectomy for severe acute cholecystitis
Laparoscopic cholecystectomy (LC) in cases with acute cholecystitis has a high risk of serious complications such as biliary tract injury and intraoperative bleeding since it is difficult to identify the appropriate dissection layer and properly grasp the gallbladder. In this session, we would like you to present a video showing how LC can be performed in such acute cholecystitis cases.
[ VSY-4 ]Lymph node and nerve plexus dissection with the SMA nerve plexus preservation for resectable pancreatic cancer
Appropriate dissection around SMA is required to achieve both curability and good postoperative QOL for patients with pancreatic cancer. In this session, we would like you to present a video showing your approach around SMA including the range of dissection and explain the surgical/oncological outcomes of your method.
[ VSY-5 ]SMA approach in laparoscopic and robotic pancreaticoduodenectomy
Minimally invasive HBP surgeries have recently been introduced. Minimally invasive pancreatoduodenectomy (MIPD) has reportedly been performed in some cases, but no specific surgical technique of MIPD has been established. In this session, we would like you to present your video demonstrating the SMA approach in MIPD (laparoscopic or robotic PD).
[ VSY-6 ]Anatomical landmarks to safely perform laparoscopic HBP surgery
Laparoscopy enables performing precise and delicate surgeries, but it also has a risk of intraoperative disorientation. It is possible that laparoscopic HBP surgery can be performed more safely by setting appropriate landmarks (organs and dissection layers) before and during surgery to avoid disorientation. In this session, we invite you to present your video showing the landmarks you use during laparoscopic HBP surgery.

Panel discussion (Open call for abstracts)

[ PD-1 ]What is the optimal multidisciplinary management strategy for advanced HCC?
Treatment options for advanced hepatocellular carcinoma (HCC) with advanced vascular invasion and multiple intrahepatic metastases include hepatectomy, embolization therapy, intraarterial infusion therapy, and molecular targeted drugs. However, the treatment results are still unsatisfactory. In this session, we would like you to show the results of multidisciplinary treatment for advanced HCC at your facility and discuss treatment strategies.
[ PD-2 ]Optimal surgical method and survival outcomes for ICC
Intrahepatic cholangiocarcinoma (ICC) is one of the HBP cancers with a poor prognosis. A standard treatment strategy has not yet been established for ICC as there are varied opinions with respect to the extent of hepatectomy according to the size and location of the tumor and the range of lymph node dissection. In this session, we would like you to present your strategy for determining the surgical method for ICC including the extent of hepatectomy and the range of lymph node dissection and show the treatment results.
[ PD-3 ]Optimal surgical method and survival outcomes for advanced gallbladder cancer
Extended surgeries such as hepato-pancreatoduodenectomy, concomitant multi-organ resection, and extrahepatic bile duct resection for radical lymph node dissection has been performed for advanced gallbladder cancer. However, no consensus has been reached on the most appropriate surgical strategy for advanced gallbladder cancer. In this session, we would like you to present the indications and results of an extended surgery for advanced gallbladder cancer at your facility.
[ PD-4 ]What is the optimal preoperative treatment for resectable and borderline resectable pancreatic cancers?
Multidisciplinary treatment is indispensable for improving the prognosis of pancreatic cancer. Preoperative treatment has also been reported to improve the prognosis of resectable pancreatic cancer. In this session, we would like you to present the indications for preoperative treatment and show the optimal chemotherapy/chemoradiotherapy regimen followed at your facility for both resectable and borderline pancreatic cancers.

Workshop (Open call for abstracts)

[ WS-1 ]Evidence-based management of postoperative drainage in HBP surgery
Perioperative drainage management is important since HBP surgery (especially highly advanced HBP surgery) often involves severe complications such as pancreatic fistula. In this session, we would like you to present your method of perioperative drainage and management.
[ WS-2 ]Management of highly advanced HBP surgery for super-elderly patients
Since elderly patients often have reduced physiological functions and various comorbidities, most of them are unsuitable for the guideline-recommended treatments. We would like you to present the surgical indications, perioperative management, and surgical results of highly invasive HBP surgery for super-elderly patients at your facility.
[ WS-3 ]Perioperative nutrition management in HBP surgery
Perioperative management programs such as Enhanced Recovery After Surgery (ERAS) has recently been reported effective for better outcomes following HBP surgery. Perioperative nutrition management is particularly important among them. In this session, we would like you to present the method of perioperative nutrition management practiced at your facility and its results as well.
[ WS-4 ]Safety of conversion surgery for unresectable pancreatic cancers
Treatment of unresectable pancreatic cancers is based on non-surgical treatment. However, conversion surgery has recently been performed following the multidisciplinary treatment with effective chemotherapy regimens such as FOLFIRINOX and Gem/nabPTX, and it has been reported to improve prognosis. On the other hand, the surgical technique and perioperative management of conversion surgery are extremely difficult. In this session, we would like you to present the surgical results of conversion surgeries performed at your center and discuss its safety.
[ WS-5 ]How to determine the transection line for IPMN
"Revisions of international consensus Fukuoka guidelines for the management of IPMN of the pancreas" published in 2017 are generally accepted and widely used for the treatment of IPMN. The cutting line of pancreatic resection is usually determined following imaging diagnosis using MDCT, MRCP, ERCP, EUS, and peroral transpapillary pancreatoscopy (POPS). However, it is difficult to determine the precise cutting line in many cases. In this session, we would like you to present your preferred preoperative diagnostic method for determining the best cutting line of pancreas.
[ WS-6 ]Surgical management of pancreatic neuroendocrine tumors
Due to rapid advances in diagnostic imaging, the number of surgery for pancreatic neuroendocrine tumors (PNET) is increasing. However, there are various surgical options for PNET such as enucleation, central pancreatectomy, splenic preserving pancreatectomy, and pancreatectomy with lymph node dissection. Indications for these surgeries and whether they are laparoscopically performed or not depend on the facility. In this session, we would like you to present the surgical strategy employed for PNET at your facility including the criteria for case and surgical method selection.

Video session (Open call for abstracts)

[ VS-1 ]Highly advanced HBP surgery by U-40 young surgeon
[ VS-2 ]Revascularization techniques in HBP surgery
[ VS-3 ]Tips and tricks: Hepatectomy for giant HCCs and CCCs
[ VS-4 ]Tips and tricks: Living donor liver transplantation
[ VS-5 ]Tips and tricks: Laparoscopic liver resection
[ VS-6 ]Laparoscopic biliary reconstruction
[ VS-7 ]Combined arterial resection in pancreatectomy for advanced pancreatic cancer
[ VS-8 ]Tips and tricks: Laparoscopic distal pancreatectomy
[ VS-9 ]Tips and tricks: Pancreatic reconstruction

Requested Session (Open call for abstracts)

[ RS-1 ]Basic research in HBP surgical field
[ RS-2 ]Long-term outcomes of the surgery for congenital biliary dilation
[ RS-3 ]Treatment strategy for bile duct stenosis after biliary reconstruction
[ RS-4 ]Surgical strategy and outcomes in duodenal cancer
[ RS-5 ]Surgical management and outcomes in pancreatic neuroendocrine tumor
[ RS-6 ]Essential anatomical points in HBP surgery

Free Paper (Oral/Poster)